homefeedbacksupportlog on 12-Oct-2008 
  Search
 
   
 
  Browse
ALL OF MEDICINE

Hematology
Anemias & Hypocellular Marrow Disorders
Bleeding & Coagulation Disorders
Hematologic Transplantation & Transfusion
Hematopoietic Stem Cells
Leukemia & Proliferative Disorders of Hematic Cells
Lymphomas & Myelomas
Non-hematopoietic Stem Cells
Pediatric Hematology
Related Sections
Perioperative Hemostasis & Transfusion Medicine

profile subject selected for My F1000 Medicine

Browse > Hematology > Leukemia & Proliferative Disorders of Hematic Cells
Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed
(from all journals) / Most viewed
(from specialty journals) / Hidden jewels		Page 1 of 7. Select Page: 1 2 3 4 5 6 7 >>
Display 10 / 20 / 50 papers per page

printer friendly 
to email [Help]

Must Read
F1000 Factor 6.0
Articles that inform your practice or change your way of thinking Changes
Clinical Practice

Confirmation
 Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy.
Griesshammer M, Struve S, Barbui T
Blood Rev 2008 Sep 22(5):235-45 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Bernard Wittels
Evaluated 8 Oct 2008

Recommended
F1000 Factor 3.0

Hypothesis
 Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
Tunstall-Pedoe O, Roy A, …, Vyas P, Roberts I
Blood 2008 Aug 8 [abstract on PubMed] [related articles] [full text]
Selected by | Christian Kratz
Evaluated 7 Oct 2008

Must Read
F1000 Factor 6.0

New Finding
 Chronic lymphocytic leukemia cells bind and present the erythrocyte protein band 3: possible role as initiators of autoimmune hemolytic anemia.
Galletti J, Cañones C, …, Gamberale R, Giordano M
J Immunol 2008 Sep 1 181(5):3674-83 [abstract on PubMed] [related articles] [order article]
Selected by | Hans U Lutz
Evaluated 6 Oct 2008

Must Read
F1000 Factor 6.0

Hypothesis
 Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells.
Taussig DC, Miraki-Moud F, …, Gribben JG, Bonnet D
Blood 2008 Aug 1 112(3):568-75 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Zhu Chen
Evaluated 25 Sep 2008

Must Read
F1000 Factor 6.0

Confirmation
 Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
Robinson KS, Williams ME, …, Lemieux B, Cheson BD
J Clin Oncol 2008 Sep 20 26(27):4473-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Kensei Tobinai
Evaluated 24 Sep 2008

Must Read
F1000 Factor 6.0

New Finding
Tech Advance
 Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.
Kujawski L, Ouillette P, …, Shedden K, Malek SN
Blood 2008 Sep 1 112(5):1993-2003 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Parameswaran Hari
Evaluated 23 Sep 2008

Recommended
F1000 Factor 3.0

Confirmation
 Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning.
Sorror ML, Storer BE, …, Storb R, Maloney DG
J Clin Oncol 2008 Sep 15 [abstract on PubMed] [related articles] [full text]
Selected by | Arnon Nagler
Evaluated 22 Sep 2008

Exceptional
F1000 Factor 9.0

Hypothesis
New Finding
 Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.
Frassoni F, Gualandi F, …, Labopin M, Bacigalupo A
Lancet Oncol 2008 Sep 9(9):831-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Bruce Camitta with Julie Talano
Evaluated 17 Sep 2008

Recommended
F1000 Factor 3.0

Hypothesis
 N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells.
Haug JS, He XC, …, Seidel C, Li L
Cell Stem Cell 2008 Apr 10 2(4):367-79 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Hector Mayani
Evaluated 12 Sep 2008

Recommended
F1000 Factor 3.0

Hypothesis
 Finding of Kinase Domain Mutations in Patients With Chronic Phase Chronic Myeloid Leukemia Responding to Imatinib May Identify Those at High Risk of Disease Progression.
Khorashad JS, de Lavallade H, …, Goldman JM, Marin D
J Clin Oncol 2008 Jul 21 [abstract on PubMed] [related articles] [full text]
Selected by | Ron Paquette
Evaluated 8 Sep 2008


top of pagePage 1 of 7. Select Page: 1 2 3 4 5 6 7 >>
Display 10 / 20 / 50 papers per page

© 2008 Medicine Reports Ltd unless otherwise stated < info@f1000.com >   Terms and conditions   Legal info